Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 51655-613

5 FDA label images from Northwind Health Company, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 51655-613). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Chemical-structure (Chemical Structure)

Chemical-structure (Chemical Structure)
Chemical structure of atorvastatin calcium, showing the molecular arrangement including calcium ion coordination and the atorvastatin moiety.*
FDA Label Image

Figure-01 (Figure 01)

Figure-01 (Figure 01)
A Kaplan-Meier curve chart illustrating cumulative incidence (%) over approximately 3.5 years, comparing Atorvastatin and Placebo groups. The solid line represents Atorvastatin, showing lower cumulative incidence compared to the dashed line for Placebo. A hazard ratio (HR) and p-value are noted at the bottom.*
FDA Label Image

Figure-02 (Figure 02)

Figure-02 (Figure 02)
A line graph comparing cumulative hazard percentages over time between Atorvastatin and placebo. The x-axis represents years from 0 to 5, indicating time to first primary endpoint through four years of follow-up. The y-axis shows cumulative hazard percentage from 0 to 15%. Two lines are plotted: a solid line for Atorvastatin and a dashed line for placebo, with placebo consistently higher. The graph includes a hazard ratio (HR) of 0.63 with confidence interval (0.48-0.83) and a p-value of 0.001.*
FDA Label Image

Figure-03 (Figure 03)

Figure-03 (Figure 03)
A line graph comparing the percentage of subjects experiencing the first major cardiovascular event over a 5-year period for two doses of atorvastatin: 10 mg (dashed line) and 80 mg (solid line). The x-axis represents time in years, and the y-axis shows the percentage of subjects experiencing the event. The graph includes a hazard ratio (HR) of 0.78 with confidence intervals and a p-value indicating statistical significance.*
FDA Label Image

Label (51655 613 83 Rev B 08 23 Nhc)

Label (51655 613 83 Rev B 08 23 Nhc)
Packaging label for Atorvastatin Calcium Tablets USP 10 mg by Northwind Health Company, LLC. The label indicates the package contains 180 film-coated tablets for oral use with NDC 51655-613-83. It includes storage instructions and notes the product is for prescription use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.